Related Experiment Video
Updated: Jul 18, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The Clinical Caveat for Treating Persistent Hypokalemia in Diabetic Ketoacidosis
Bashar Khiatah1, Amanda Frugoli2,3, Deborah Carlson3,4
1Internal Medicine, Overlake Medical Center, Bellevue, USA.
Abstract:
The medical community seeks to provide evidence-based guidelines for treating any disease to ensure optimal care delivery. Occasionally, a patient's unique physiology does not respond to guideline-driven treatments and requires experienced clinical personalization for treatment. Failure of clinicians to recognize patient outliers and augment care can delay treatment, provide substandard care, and potentially threaten a patient's life. This paper describes a clinical caveat for treating profound or persistent hypokalemia in patients with DKA (diabetic ketoacidosis).
More Related Videos
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
Chronic Kidney Disease II: Clinical Manifestations

